PTC Therapeutics Quote, Financials, Valuation and Earnings

PTC Therapeutics Price Quote

-0.03 (0.96%)
(Updated: June 10, 2023 at 5:25 AM ET)

PTC Therapeutics Key Stats

PTC Therapeutics (PTCT) is a Sell

Day range:
$42.07 - $43.42
52-week range:
$25.01 - $59.84
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does PTC Therapeutics Make?

Is PTC Therapeutics Growing As A Company?

  • What Is PTC Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PTC Therapeutics Stock Price Performance

  • Did PTC Therapeutics Stock Go Up Last Month?
    PTC Therapeutics share price went down by -23.13% last month
  • Did PTCT's Share Price Rise Over The Last Year?
    PTCT share price rose by 54.4% over the past 1 year

What Is PTC Therapeutics 52-Week High & Low?

PTC Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PTC Therapeutics?

  • How Much Debt Does PTC Therapeutics Have?
    Total long term debt quarterly is $572.1M
  • How Much Cash Does PTC Therapeutics Have?
    Cash and short term investments quarterly total is $286.3M
  • What Is PTC Therapeutics’s Book Value Per Share?
    Book value per share is -6.18

Is PTC Therapeutics Cash Flow Positive?

  • What Is PTCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$288.7M
  • What Is PTC Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $170.9M
  • What Is PTC Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $212.2M

PTC Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PTCT return on invested capital is -289.54%
  • What Is PTC Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -33.63%
  • What Is PTCT Return On Equity?
    ROE is a measure of profitability and is 0%

PTC Therapeutics Earnings Date & Stock Price

PTC Therapeutics Competitors

  • Who Are PTC Therapeutics's Competitors?
    Below is a list of companies who compete with PTC Therapeutics or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Immunogen Inc (IMGN)
    • Pyxis Oncology Inc (PYXS)
    • Reata Pharmaceuticals Inc (RETA)
    • Cassava Sciences Inc (SAVA)

PTC Therapeutics Dividend Yield

Data Unavailable

PTC Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -15.34%
Revenue: 48.17% 9.93%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 54.20
Upside from Last Price: 26.05%

Major Shareholders

  • How many PTCT shares are owned by institutional investors?
    123.7M PTCT shares are owned by institutional investors
  • How many PTCT shares are owned by insiders?
    948.5K PTCT shares are owned by insiders